Literature DB >> 6420818

Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status.

A D Crocker, D H Overstreet.   

Abstract

Rats made hypothyroid by the chronic oral administration of 200 mg/kg propylthiouracil were less sensitive to the cataleptic effects of haloperidol (0.1 mg/kg) treatment than were euthyroid rats chronically treated with isotonic saline. However, rats made hyperthyroid by the chronic injection of 200 micrograms/kg thyroxine were not more sensitive to the cataleptic suppressant effects of haloperidol (0.1 mg/kg). Higher doses of haloperidol (1 and 5 mg/kg) produced significantly greater catalepsy in the hyperthyroid rats and significantly reduced catalepsy in the hypothyroid rats. Receptor binding studies carried out on the striata from rats sacrificed 48 h after a 6-day course of chronic haloperidol (0.1 mg/kg once daily) treatment revealed a significant upregulation (increase) of dopamine receptors in the hypothyroid rats only. These findings are consistent with the hypothesis that altered thyroid status can modify the sensitivity of dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420818     DOI: 10.1007/bf00426390

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.

Authors:  U Strömbom; T H Svensson; D M Jackson; G Engström
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

2.  The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.

Authors:  B Costall; R J Naylor
Journal:  Neuropharmacology       Date:  1974-05       Impact factor: 5.250

3.  Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs.

Authors:  H L Klawans; C Goetz; W J Weiner
Journal:  Adv Neurol       Date:  1974

4.  Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.

Authors:  G Engström; T H Svensson; B Waldeck
Journal:  Brain Res       Date:  1974-09-13       Impact factor: 3.252

5.  Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism.

Authors:  C R Lake; W E Fann
Journal:  Br J Psychiatry       Date:  1973-11       Impact factor: 9.319

6.  Catecholamines: diminished rate of synth- esis in rat brain and heart after thyroxine pretreatment.

Authors:  A J Prange; J L Meek; M A Lipton
Journal:  Life Sci I       Date:  1970-08-15

7.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

8.  Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry.

Authors:  C K Atterwill
Journal:  Neuropharmacology       Date:  1981-02       Impact factor: 5.250

9.  Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin.

Authors:  N W Pedigo; T Schallert; D H Overstreet; N C Ling; P Ragan; T D Reisine; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1979-12-20       Impact factor: 4.432

10.  Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain.

Authors:  J M Ito; T Valcana; P S Timiras
Journal:  Neuroendocrinology       Date:  1977       Impact factor: 4.914

  10 in total
  4 in total

1.  Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity.

Authors:  R Wong; V V Vasilyev; Y T Ting; D I Kutler; M C Willingham; B D Weintraub; S Cheng
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

2.  Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study.

Authors:  Chao Li; Zhenchun Shi; Jiacui Ji; Gengyun Niu; Zengxun Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-10       Impact factor: 2.570

3.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

4.  Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review.

Authors:  Ruohollah Seddigh; Somayeh Azarnik; Amir-Abbas Keshavarz-Akhlaghi
Journal:  Case Rep Psychiatry       Date:  2015-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.